Letters
Overtreatment
Response to Whitehead
BMJ 2012; 345 doi: https://doi.org/10.1136/bmj.e7088 (Published 24 October 2012) Cite this as: BMJ 2012;345:e7088
- David Colquhoun, research professor
- 1UCL, London WC1E 6BT, UK
- d.colquhoun{at}ucl.ac.uk
I guess one would expect the chief executive of the Association of the British Pharmaceutical Industry to respond by denying everything.1 2 But it is very condescending to …
Log in
Log in using your username and password
Log in through your institution
Subscribe from £184 *
Subscribe and get access to all BMJ articles, and much more.
* For online subscription
Access this article for 1 day for:
£50 / $60/ €56 (excludes VAT)
You can download a PDF version for your personal record.